Adlai Nortye Ltd. (ANL)
NASDAQ: ANL · Real-Time Price · USD
11.06
-0.29 (-2.56%)
Jul 17, 2026, 9:48 AM EDT - Market open
Adlai Nortye Market Cap
Adlai Nortye has a market cap or net worth of $442.4 million as of July 17, 2026. Its market cap has increased by 693.98% in one year.
Market Cap
442.40M
Enterprise Value
471.42M
1-Year Change
693.98%
Ranking
Category
Stock Price
$11.06
ChartMarket Cap Chart
Since the IPO on September 29, 2023, Adlai Nortye's market cap has decreased from $553.50M to $442.40M, a decrease of -20.07%. That is a compound annual growth rate of -7.69%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2026 | 442.40M | 744.31% |
| Dec 31, 2025 | 52.40M | -47.12% |
| Dec 31, 2024 | 99.08M | -70.13% |
| Dec 29, 2023 | 331.73M | -40.07% |
| Sep 29, 2023 | 553.50M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Benitec Biopharma | 447.29M |
| Prelude Therapeutics | 442.33M |
| Prothena Corporation | 441.34M |
| Sutro Biopharma | 430.83M |
| Puma Biotechnology | 428.06M |
| Eupraxia Pharmaceuticals | 426.44M |
| C4 Therapeutics | 420.16M |
| Abeona Therapeutics | 415.49M |